在莫亚莫亚血管病的精密医学
Ritik Patel1, Muhammad Memon2, Johnny A Mendoza1
1Wayne State University School of Medicine.
Current opinion in neurology
|December 8, 2025
概括
莫亚莫亚病的管理正在通过综合的遗传,成像和生物标记数据取得进展. 这种多组方法有望改善患者分层,诊断和个性化治疗策略,以治疗这种渐进性脑血管疾病.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 是一个遗传学.
- 生物标志物 生物标志物
背景情况:
- 莫亚莫亚血管病是一种进展性脑血管狭性闭塞性疾病,具有不同的临床表现.
- 再血管化,抗血小板治疗和人工智能诊断方面的进展为患者管理提供了新的途径.
研究的目的:
- 通过整合基因分析,神经成像表型和循环生物标志物来完善莫亚莫亚病患者分层.
- 探索Moyamoya血管病变的新兴诊断和治疗策略.
主要方法:
- 关于遗传易感性 (RNF213,ACTA2,GUCY1A3),分子途径 (脂质代谢,氧化信号,氧化应激) 和蛋白质组发现的当前文献的综述.
- 分析诊断标准,包括MRI/MRA和数字减去血管学 (DSA).
- 评估复血管化技术 (直接,间接,联合绕道) 和抗血小板疗法 (例如,西洛斯塔).
- 评估新兴的AI集成诊断算法,包括多原子数据.
主要成果:
- 在东亚人群中,RNF213 (p.R4810K) 是主要敏感性等位基因;ACTA2和GUCY1A3是次要贡献者.
- 不调节的脂质代谢,氧化信号传递,氧化应激和铁亡途径都与此有关.
- 蛋白质组学研究揭示了血管和细胞骨程序的破坏,在脑脊液和血清中具有潜在的生物标志物实用性.
- 抗血小板药物,如西洛斯塔,在减少中风复发方面表现有前途.
- 直接/组合绕道对于成年出血的莫亚莫亚更优越,而对于儿科病例而言,偏向于间接再血管化.
- 人工智能集成的算法显示出有希望的诊断准确性.
结论:
- 将基因型和多组基因分析与血液动力学评估相结合,可以提高预后的准确性并指导治疗决策.
- 未来的研究应该专注于针对性/再生疗法的多中心注册和试验.
- 以DSA为指导的诊断和个性化再血管化仍然是临床标准.
更多相关视频
07:25Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
3.7K
09:36A Magnetic Resonance Imaging-based Computational Protocol for Analysis of Plaque Morphology and Hemodynamics in Patients with Carotid Artery Stenosis
Published on: August 12, 2025
518
相关概念视频
Mitral Stenosis III: Medical Management
223
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
223
Peripheral Artery Disease III: Interprofessional Care
226
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
226
Atherosclerosis III: Management
296
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
296
Coronary Artery Disease V: Interprofessional Care
205
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
205
